{"id":6567,"date":"2023-03-21T00:24:01","date_gmt":"2023-03-21T00:24:01","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6567"},"modified":"2023-08-29T17:57:20","modified_gmt":"2023-08-29T17:57:20","slug":"inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6567","title":{"rendered":"InhaleRx \u9501\u5b9a\u65b0\u836f IRX211 \u6cbb\u7597 CRPS \u7684\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6"},"content":{"rendered":"<p>InhaleRx (ASX: IRX) \u5728\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u540e\uff0c\u8ddd\u79bb\u542f\u52a8\u5176\u65b0\u578b\u5438\u5165\u5927\u9ebb\u7d20\u5236\u5242 IRX211\u6cbb\u7597\u590d\u6742\u533a\u57df\u75bc\u75db\u7efc\u5408\u5f81 (CRPS) \u7684\u7b2c\u4e00\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002<\/p>\n<p>Alfred Health Human Ethics Committee (HREC) \u6279\u51c6\u4e86\u8be5\u8bd5\u9a8c\uff0c\u8be5\u8bd5\u9a8c\u5c06\u5728\u58a8\u5c14\u672c\u7684 Nucleus Network \u7814\u7a76 IRX211 \u7684\u5b89\u5168\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u3002<\/p>\n<p>Nucleus Network \u662f\u4e00\u4e2a\u4e13\u6ce8\u4e14\u7ecf\u9a8c\u4e30\u5bcc\u7684\u8bd5\u9a8c\u4e2d\u5fc3\uff0c\u8be5\u7814\u7a76\u5c06\u6d89\u53ca\u56db\u7ec4\u516b\u540d\u53c2\u4e0e\u8005\uff0c\u4ed6\u4eec\u5c06\u63a5\u53d7 IRX211 \u6216\u5b89\u6170\u5242\u3002<\/p>\n<p>\u6700\u8fd1\u4efb\u547d\u7684\u5408\u540c\u7814\u7a76\u7ec4\u7ec7 Ingenu CRO \u5c06\u7ba1\u7406\u8bd5\u9a8c\uff0c\u60a3\u8005\u62db\u52df\u8ba1\u5212\u4e8e 5 \u6708\u5f00\u59cb\uff0c\u6279\u91cf\u751f\u4ea7\u5c06\u4e8e\u4e0b\u4e2a\u6708\u5f00\u59cb\u3002<\/p>\n<p>\u5b83\u65e8\u5728\u8bc1\u660e\u836f\u7269-\u8bbe\u5907\u7ec4\u5408\u7684\u5b89\u5168\u6027\u5e76\u786e\u5b9a II \u671f\u8bd5\u9a8c\u7684\u6700\u4f73\u5242\u91cf\u3002<\/p>\n<h2>\u201c\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u201d<\/h2>\n<p>InhaleRx \u9996\u5e2d\u6267\u884c\u5b98 Darryl Davies \u8868\u793a\uff0c\u83b7\u5f97\u5f00\u59cb\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u6279\u51c6\u662f\u4e00\u4e2a\u201c\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u201d\u3002<\/p>\n<p>IRX211 \u662f\u4e00\u79cd\u5927\u9ebb\u7d20\u884d\u751f\u836f\u7269\u5c48\u5927\u9ebb\u915a (THC)\uff0c\u901a\u8fc7\u56fa\u5b9a\u5242\u91cf\u5438\u5165\u7ed9\u836f\u4ee5\u89e3\u51b3\u590d\u6742\u6027\u5c40\u90e8\u75bc\u75db\u7efc\u5408\u5f81\uff08CRPS\uff09\u3002<\/p>\n<p>Davies \u5148\u751f\u8bf4\uff0c\u8d8a\u6765\u8d8a\u591a\u7684\u60a3\u8005\u4f7f\u7528\u5927\u9ebb\u7d20\u6765\u6cbb\u7597\u4e00\u7cfb\u5217\u75bc\u75db\u969c\u788d\u3002<\/p>\n<p>\u201c\u8fd9\u79cd\u8bbe\u5907 \u2014\u2014 \u836f\u7269\u7ec4\u5408\u7684\u72ec\u7279\u8bbe\u8ba1\u5c06\u4f7f\u60a3\u8005\u80fd\u591f\u6709\u4e00\u4e2a\u5feb\u901f\u8d77\u6548\u7684\u89e3\u51b3\u65b9\u6848\u6765\u5e2e\u52a9\u7ba1\u7406\u7a81\u7834\u6027\u75bc\u75db\u53d1\u4f5c\uff0c\u201d\u4ed6\u8865\u5145\u8bf4\u3002<\/p>\n<h2>\u590d\u6742\u6027\u5c40\u90e8\u75bc\u75db\u7efc\u5408\u75c7 \uff08CRPS\uff09<\/h2>\n<p>\u6cbb\u7597 CRPS \u7684\u5168\u7403\u5e74\u5ea6\u5e02\u573a\u89c4\u6a21\u6bcf\u5e74\u8d85\u8fc7 70.8 \u4ebf\u7f8e\u5143\u3002<\/p>\n<p>\u8be5\u75be\u75c5\u4e5f\u6709\u8d44\u683c\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u7684\u5b64\u513f\u836f\u6307\u5b9a (ODD)\u3002<\/p>\n<p>\u83b7\u5f97 ODD \u5177\u6709\u5546\u4e1a\u4f18\u52bf\uff0c\u5305\u62ec\u5728\u83b7\u5f97 FDA \u65b0\u836f\u6279\u51c6\u540e\u7684\u6392\u4ed6\u6027\u3002<\/p>\n<p>InhaleRx \u6b63\u5728\u901a\u8fc7 FDA \u7684\u76d1\u7ba1\u9014\u5f84\u63a8\u8fdb IRX211\uff0c\u5e76\u5df2\u9884\u8ba2\u4e86 3 \u6708 30 \u65e5\u7684\u9884\u7814\u7a76\u65b0\u836f\u4f1a\u8bae\u3002<\/p>\n<p>\u4f1a\u8bae\u5c06\u8ba8\u8bba\u5f00\u53d1 IRX211 \u4ee5\u5728\u7f8e\u56fd\u83b7\u5f97\u6279\u51c6\u7684\u540e\u7eed\u6b65\u9aa4\u3002<\/p>\n<p>\u4f5c\u4e3a\u5176\u4e2d\u7684\u4e00\u90e8\u5206\uff0cInhaleRx \u5c06\u4e3a IRX211 \u5f00\u8f9f\u4e00\u9879\u6cbb\u7597 CRPS \u7684\u7814\u7a76\u65b0\u836f\u7533\u8bf7\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>InhaleRx (ASX: IRX) \u5728\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u540e\uff0c\u8ddd\u79bb\u542f\u52a8\u5176\u65b0\u578b\u5438\u5165\u5927\u9ebb\u7d20\u5236\u5242 IRX211\u6cbb\u7597\u590d\u6742\u533a\u57df\u75bc\u75db\u7efc\u5408\u5f81 (CRPS) \u7684\u7b2c\u4e00\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002 Alfred Health Human Ethics Committee (HREC) \u6279\u51c6\u4e86\u8be5\u8bd5\u9a8c\uff0c\u8be5\u8bd5\u9a8c\u5c06\u5728\u58a8\u5c14\u672c\u7684 Nucleus Network \u7814\u7a76 IRX211 \u7684\u5b89\u5168\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u3002 Nucleus Network \u662f\u4e00\u4e2a\u4e13\u6ce8\u4e14\u7ecf\u9a8c\u4e30\u5bcc\u7684\u8bd5\u9a8c\u4e2d\u5fc3\uff0c\u8be5\u7814\u7a76\u5c06\u6d89\u53ca\u56db\u7ec4\u516b\u540d\u53c2\u4e0e\u8005\uff0c\u4ed6\u4eec\u5c06\u63a5\u53d7 IRX211 \u6216\u5b89\u6170\u5242\u3002 \u6700\u8fd1\u4efb\u547d\u7684\u5408\u540c\u7814\u7a76\u7ec4\u7ec7 Ingenu CRO \u5c06\u7ba1\u7406\u8bd5\u9a8c\uff0c\u60a3\u8005\u62db\u52df\u8ba1\u5212\u4e8e 5 \u6708\u5f00\u59cb\uff0c\u6279\u91cf\u751f\u4ea7\u5c06\u4e8e\u4e0b\u4e2a\u6708\u5f00\u59cb\u3002 \u5b83\u65e8\u5728\u8bc1\u660e\u836f\u7269-\u8bbe\u5907\u7ec4\u5408\u7684\u5b89\u5168\u6027\u5e76\u786e\u5b9a II \u671f\u8bd5\u9a8c\u7684\u6700\u4f73\u5242\u91cf\u3002 \u201c\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u201d InhaleRx \u9996\u5e2d\u6267\u884c\u5b98 Darryl Davies \u8868\u793a\uff0c\u83b7\u5f97\u5f00\u59cb\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u6279\u51c6\u662f\u4e00\u4e2a\u201c\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u201d\u3002 IRX211 \u662f\u4e00\u79cd\u5927\u9ebb\u7d20\u884d\u751f\u836f\u7269\u5c48\u5927\u9ebb\u915a (THC)\uff0c\u901a\u8fc7\u56fa\u5b9a\u5242\u91cf\u5438\u5165\u7ed9\u836f\u4ee5\u89e3\u51b3\u590d\u6742\u6027\u5c40\u90e8\u75bc\u75db\u7efc\u5408\u5f81\uff08CRPS\uff09\u3002 Davies \u5148\u751f\u8bf4\uff0c\u8d8a\u6765\u8d8a\u591a\u7684\u60a3\u8005\u4f7f\u7528\u5927\u9ebb\u7d20\u6765\u6cbb\u7597\u4e00\u7cfb\u5217\u75bc\u75db\u969c\u788d\u3002 \u201c\u8fd9\u79cd\u8bbe\u5907 \u2014\u2014 \u836f\u7269\u7ec4\u5408\u7684\u72ec\u7279\u8bbe\u8ba1\u5c06\u4f7f\u60a3\u8005\u80fd\u591f\u6709\u4e00\u4e2a\u5feb\u901f\u8d77\u6548\u7684\u89e3\u51b3\u65b9\u6848\u6765\u5e2e\u52a9\u7ba1\u7406\u7a81\u7834\u6027\u75bc\u75db\u53d1\u4f5c\uff0c\u201d\u4ed6\u8865\u5145\u8bf4\u3002 \u590d\u6742\u6027\u5c40\u90e8\u75bc\u75db\u7efc\u5408\u75c7 \uff08CRPS\uff09 \u6cbb\u7597 CRPS \u7684\u5168\u7403\u5e74\u5ea6\u5e02\u573a\u89c4\u6a21\u6bcf\u5e74\u8d85\u8fc7 70.8 \u4ebf\u7f8e\u5143\u3002 \u8be5\u75be\u75c5\u4e5f\u6709\u8d44\u683c\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u7684\u5b64\u513f\u836f\u6307\u5b9a&hellip; <a class=\"more-link\" href=\"https:\/\/smallcapscn.x5view.co\/?p=6567\">Continue reading <span class=\"screen-reader-text\">InhaleRx \u9501\u5b9a\u65b0\u836f IRX211 \u6cbb\u7597 CRPS \u7684\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":18699,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[1027],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>InhaleRx \u9501\u5b9a\u65b0\u836f IRX211 \u6cbb\u7597 CRPS \u7684\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6<\/title>\n<meta name=\"description\" content=\"InhaleRx (ASX: IRX) \u5728\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u540e\uff0c\u8ddd\u79bb\u542f\u52a8\u5176\u65b0\u578b\u5438\u5165\u5927\u9ebb\u7d20\u5236\u5242 IRX211\u6cbb\u7597\u590d\u6742\u533a\u57df\u75bc\u75db\u7efc\u5408\u5f81 (CRPS) \u7684\u7b2c\u4e00\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"InhaleRx \u9501\u5b9a\u65b0\u836f IRX211 \u6cbb\u7597 CRPS \u7684\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6\" \/>\n<meta property=\"og:description\" content=\"InhaleRx (ASX: IRX) \u5728\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u540e\uff0c\u8ddd\u79bb\u542f\u52a8\u5176\u65b0\u578b\u5438\u5165\u5927\u9ebb\u7d20\u5236\u5242 IRX211\u6cbb\u7597\u590d\u6742\u533a\u57df\u75bc\u75db\u7efc\u5408\u5f81 (CRPS) \u7684\u7b2c\u4e00\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-21T00:24:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:57:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/InhaleRx-ASX-IRX-complex-regional-pain-syndrome-CRPS-ethics-approval-Phase-1-Nucleus-Network.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/\",\"name\":\"InhaleRx \u9501\u5b9a\u65b0\u836f IRX211 \u6cbb\u7597 CRPS \u7684\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-03-21T00:24:01+00:00\",\"dateModified\":\"2023-08-29T17:57:20+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"InhaleRx (ASX: IRX) \u5728\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u540e\uff0c\u8ddd\u79bb\u542f\u52a8\u5176\u65b0\u578b\u5438\u5165\u5927\u9ebb\u7d20\u5236\u5242 IRX211\u6cbb\u7597\u590d\u6742\u533a\u57df\u75bc\u75db\u7efc\u5408\u5f81 (CRPS) \u7684\u7b2c\u4e00\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InhaleRx \u9501\u5b9a\u65b0\u836f IRX211 \u6cbb\u7597 CRPS \u7684\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"InhaleRx \u9501\u5b9a\u65b0\u836f IRX211 \u6cbb\u7597 CRPS \u7684\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6","description":"InhaleRx (ASX: IRX) \u5728\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u540e\uff0c\u8ddd\u79bb\u542f\u52a8\u5176\u65b0\u578b\u5438\u5165\u5927\u9ebb\u7d20\u5236\u5242 IRX211\u6cbb\u7597\u590d\u6742\u533a\u57df\u75bc\u75db\u7efc\u5408\u5f81 (CRPS) \u7684\u7b2c\u4e00\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"InhaleRx \u9501\u5b9a\u65b0\u836f IRX211 \u6cbb\u7597 CRPS \u7684\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6","og_description":"InhaleRx (ASX: IRX) \u5728\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u540e\uff0c\u8ddd\u79bb\u542f\u52a8\u5176\u65b0\u578b\u5438\u5165\u5927\u9ebb\u7d20\u5236\u5242 IRX211\u6cbb\u7597\u590d\u6742\u533a\u57df\u75bc\u75db\u7efc\u5408\u5f81 (CRPS) \u7684\u7b2c\u4e00\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/","og_site_name":"smallcapsCN","article_published_time":"2023-03-21T00:24:01+00:00","article_modified_time":"2023-08-29T17:57:20+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/InhaleRx-ASX-IRX-complex-regional-pain-syndrome-CRPS-ethics-approval-Phase-1-Nucleus-Network.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/","url":"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/","name":"InhaleRx \u9501\u5b9a\u65b0\u836f IRX211 \u6cbb\u7597 CRPS \u7684\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-03-21T00:24:01+00:00","dateModified":"2023-08-29T17:57:20+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"InhaleRx (ASX: IRX) \u5728\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u540e\uff0c\u8ddd\u79bb\u542f\u52a8\u5176\u65b0\u578b\u5438\u5165\u5927\u9ebb\u7d20\u5236\u5242 IRX211\u6cbb\u7597\u590d\u6742\u533a\u57df\u75bc\u75db\u7efc\u5408\u5f81 (CRPS) \u7684\u7b2c\u4e00\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/inhalerx-ethics-approval-phase-1-trial-novel-drug-irx211-treating-crps\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"InhaleRx \u9501\u5b9a\u65b0\u836f IRX211 \u6cbb\u7597 CRPS \u7684\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6567"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6567"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6567\/revisions"}],"predecessor-version":[{"id":20365,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6567\/revisions\/20365"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18699"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}